The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Saphnelo
Australian Public Assessment Report
Device/Product Name
Saphnelo
Active ingredients
Anifrolumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-06383-1-2
Submission Type
New biological entity
Decision
Approved